These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7620761)

  • 1. Schizophreniform psychosis after stage hypnosis.
    Allen DS
    Br J Psychiatry; 1995 May; 166(5):680. PubMed ID: 7620761
    [No Abstract]   [Full Text] [Related]  

  • 2. [Organic schizophreniform disorder with pre-existing autoimmune thyroiditis].
    Gruber E; Algermissen C; Ebel H
    Nervenarzt; 2003 Nov; 74(11):1012-5. PubMed ID: 14598039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotic Features of Turner Syndrome.
    Pestana PC; Silva ID; Ferreira ALB; Duarte TA; Loureiro S
    Prim Care Companion CNS Disord; 2018 Oct; 20(5):. PubMed ID: 30407757
    [No Abstract]   [Full Text] [Related]  

  • 4. [Postictal paranoid-hallucinatory psychosis in cryptogenic epilepsy].
    Baum P; Kopf A; Hermann W; Wagner A
    Psychiatr Prax; 2007 Jul; 34(5):249-57. PubMed ID: 18217221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxedema madness: a case for short-term antipsychotics?
    Hynicka LM
    Ann Pharmacother; 2015 May; 49(5):607-8. PubMed ID: 25870443
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease.
    Voon V; Lang AE
    Clin Neuropharmacol; 2004; 27(2):90-2. PubMed ID: 15252271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.
    Panchal SC; Ondo WG
    Curr Psychiatry Rep; 2018 Jan; 20(1):3. PubMed ID: 29374325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hallucinations and psychosis in Parkinson's disease.
    Eng ML; Welty TE
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):316-30. PubMed ID: 20869621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical versus psychopathological action profile of neuroleptics: a comparative study of chlorpromazine and oxypertine in acute psychotic disorders.
    van Praag HM; Dols LC; Schut T
    Compr Psychiatry; 1975; 16(3):255-63. PubMed ID: 237735
    [No Abstract]   [Full Text] [Related]  

  • 10. Delusional.
    Abraham S
    Schizophr Bull; 2020 Dec; 46(6):1339-1340. PubMed ID: 31355406
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled trial of penfluridol in acute psychosis.
    van Praag HM; Schut T; Dols L; van Schilfgaarden R
    Br Med J; 1971 Dec; 4(5789):710-3. PubMed ID: 4943034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol versus chlorpromazine in the treatment of psychoses associated with childbearing.
    Steiner M; Latz A; Blum I; Atsmon A; Wijsenbeek H
    Psychiatr Neurol Neurochir; 1973; 76(6):421-6. PubMed ID: 4781521
    [No Abstract]   [Full Text] [Related]  

  • 13. Pimavanserin: A Novel Antipsychotic for Parkinson's Disease Psychosis.
    Bozymski KM; Lowe DK; Pasternak KM; Gatesman TL; Crouse EL
    Ann Pharmacother; 2017 Jun; 51(6):479-487. PubMed ID: 28375643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.
    De Deyn PP; Carrasco MM; Deberdt W; Jeandel C; Hay DP; Feldman PD; Young CA; Lehman DL; Breier A
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):115-26. PubMed ID: 14758577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallucinations and the spectrum of psychosis in Parkinson's disease.
    Frei K; Truong DD
    J Neurol Sci; 2017 Mar; 374():56-62. PubMed ID: 28108020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Delusional parasitosis: case report].
    Jakuszkowiak-Wojten K; Cubała WJ; Szeliga-Lewińska J
    Psychiatr Pol; 2007; 41(4):571-8. PubMed ID: 18046987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief Psychotic Disorder During the National Lockdown in Italy: An Emerging Clinical Phenomenon of the COVID-19 Pandemic.
    D Agostino A; D'Angelo S; Giordano B; Cigognini AC; Chirico ML; Redaelli C; Gambini O
    Schizophr Bull; 2021 Jan; 47(1):15-22. PubMed ID: 32761196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [First manifestation of psychosis].
    Hambrecht M
    MMW Fortschr Med; 2008 Jun; 150(26-27):51. PubMed ID: 18683308
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipsychotic treatment improves outcome in herpes simplex encephalitis: a case report.
    Guaiana G; Markova I
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):247. PubMed ID: 16720808
    [No Abstract]   [Full Text] [Related]  

  • 20. Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis.
    Kianirad Y; Simuni T
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1161-1168. PubMed ID: 28817967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.